Share

Related Stories

  • A hormone that fights fat with fat
    Sanford-Burnham scientists reveal that a hormone called orexin prevents obesity in mice by activating brown fat, a tissue that’s good at burning calories.
  • Leeds scientists to lead groundbreaking investigation into treatment of cervical cancer
    A pioneering investigation into the treatment of cervical cancer will take place at the University of Leeds following a major advancement in the study of the disease.
  • Babraham scientists reveal how white blood cells get activated in auto-immune disease, helping to target better drugs for these disorders
    Scientists at the Babraham Institute have discovered a critical piece of the jigsaw that explains how a type of immune cell – a white blood cell known as a neutrophil – is activated by antibodies. The research, published today in the journal Science Signaling, brings new understanding to how the Phosphatidylinositol 3-kinase (PI3K) signalling pathway is used to regulate neutrophil function. This may pave the way for the development of a strategy to specifically inhibit the inappropriate activation of these immune cells that is seen in auto-immune inflammatory conditions such as rheumatoid arthritis, glomerulonephritis and some skin blistering diseases.
  • Why stem cells don't just want to make neurons
    Research being presented today (01 April) at the UK National Stem Cell Network annual science conference provides another piece in the puzzle of why it can be so hard to produce large numbers of the same type of cell in the lab - a process that is vital for scaling up stem cell production for therapeutic use. This knowledge will help researchers to develop strategies for obtaining the desired cell type for use in either research or medicine.
  • Scientists strive to make new drugs ‘like house guests from hell’
    Designing drugs to be like house guests from hell – reluctant to leave, despite their host’s best efforts - may hold the key to more effective treatment of cancers and brain diseases like Alzheimer's.

Top 5 Stories

News

Supply and demand

04 August 2010

Scientists at the European Molecular Biology Laboratory have discovered that a group of proteins named IRPs ensure that the iron balance is maintained in cells and, as such, are essential for cell survival.

Most organisms need iron to survive, but too much iron is toxic and can cause fatal organ failure. The same is true inside cells, where iron balance must also be maintained.

In a study published in Cell Metabolism, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have shown that IRPs ensure the iron balance is maintained in cells. More specifically, the scientists found that IRPs are required for the functioning of mitochondria.

Mitochondria need iron to function, but they also convert iron into other chemical forms used throughout the cell: iron sulphur clusters and haem, one of the building blocks of haemoglobin. Thanks to new mouse models they engineered, the scientists were able to selectively shut down IRP function in specific cell types.

‘Mice whose liver cells can’t produce IRPs die of liver failure a few days after birth,’ says Bruno Galy, Staff Scientist in Matthias Hentze’s group at EMBL, who spearheaded the work. ‘The mitochondria in those cells have structural defects and don’t function properly, because they don’t have enough iron.’

In cells that cannot produce IRPs, the mechanisms for iron export and storage go into overdrive, while iron import is drastically reduced. This combination of factors leads to an iron shortage in the cell.

The role of IRPs is to ensure that there is enough iron available in the cell to sustain mitochondrial iron needs.

‘We have indications that this is probably a general process by which most cells control their iron content and secure mitochondrial iron sufficiency,’ Hentze concludes.

This might be a double-edged sword: there are situations in which mitochondria get iron but are not able to make use of it. This ultimately results in detrimental iron overloading of mitochondria.

This might underlie the pathology of several diseases, including inherited sideroblastic anaemias and the neurodegenerative disorder Friedreich’s ataxia, which the EMBL scientists are currently investigating.

Further reading

Galy, B. et al. (2010) Iron regulatory proteins secure mitochondrial iron sufficiency and function. Cell Metabolism, 12, 194–201

 

This article is featured in:
Target Identification/ Validation

 

Comment on this article

You must be registered and logged in to leave a comment about this article.